Skip to content
CDMO SERVICES FOR PROTEINS & ANTIBODIES

Biosimilars and Biobetters

You want to create a high-performance biosimilar or a biobetter with improved product properties at a reasonable cost? 

Our expertise in generating mammalian cell-derived biosimilars has been honed for over a decade and helps us ensure reliability and rapid progress. Transitioning seamlessly from market-ready biosimilars to our innovative biobetters, we pave the way for cost-effective solutions that elevate patient care. 

IN A NUTSHELL

Biosimilars and Biobetters for Affordable Treatments

Relying on our proprietary technologies, we provide you with a smart cell line and process development as well as the secure manufacture of clinical batches in a timely manner. The entire process is monitored and controlled by head-to-head comparison to the reference medicinal product (RMP) and complemented by a biosimilarity assessment to ensure similarity. 

Biosimilars and Biobetters_Proteins copy 2-01
HOW WE WORK

Our Expertise - Your Success

One-Stop-Shop
Fully Centered on Quality and Compliance
Proprietary Vectors, Media Platform and Best-in-Class Technologies
Integrated Analytics
Process Development for Biosimilars
Product Characterization & Biosimilarity Assessment

Types of Molecules We’ve Worked With

Biosimilars and Biobetters_Molecule List-03

Our Promise to You

Rely on Fast Timelines

  • One-Stop-Shop with seamless, integrated Services
  • Parallel Processes
  • Efficient project execution
  • Do it right from the beginning

Get Your High Quality Candidate

  • Scientific excellence
  • Deep understanding for molecule / Long + broad experience
  • Strong Analytics teams and stellar quality management services
  • Enabling technologies

Have the Flexibility You Need

  • Modular Offering
  • Customer Centricity/ Strong Partnership Approach
  • Experienced Project Managers and efficient decision-making

Our Promise To You

Asset 20
 
Comparability Secured
  • Comprehensive originator assessment for a reliable quality target product profile (QTPP) 
  • Early biosimilar candidate testing to adjust and align with the critical quality attributes (CQA)  
  • Superior technologies to adjust and boost performance 
Asset 68
 
Maximum Reliability
  • Highly experienced project teams headed by our project management office (PMO) 
  • Integrated development, GMP manufacturing, and analytics 
  • Similarity and compliance through quality by design (QbD)
Time is Money
 
Reasonable Costs and Timelines
  • Efficient process development, manufacturing, and reports 
  • Cost efficient development and manufacturing achieved by controlling the cost of goods (CoGs) and scaling to demand  
  • Fast track approach with accelerated timelines in CLD, USP, and DSP

Elevate Your Candidate With The Right CDMO

Discover Related Services

Explore Protein Technologies

Explore Related Content

Blog Header template-1
Sugar-Sweet Success: Enhancing Antibody Therapeutics Through Precision Glycoengineering

Blog Post

Process_Intensification_in_Upstream_Processing_Blog_small-1
Investing in Efficiency: Benefits of Process Intensification in Upstream Processing

Blog Post

ProBioGen_Laboratory_Media_100px
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services

Press Release

L1430743_ProBioGen_PCLD_Supplementierung_Zellkulturmedium_100px_gedreht
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy

Press Release

Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.